![N-[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine](https://static.cymitquimica.com/cas-image/340178-n-2-3-pyridinyl-6-1245-tetrahydro-3h-3-benzazepin-3-yl-4-pyrimidinyl-b-alanine.png)
CAS: 1394854-52-4 - N-[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine
Formula:C22H23N5O2
InChI:InChI=1S/C22H23N5O2/c28-21(29)7-11-24-19-14-20(26-22(25-19)18-6-3-10-23-15-18)27-12-8-16-4-1-2-5-17(16)9-13-27/h1-6,10,14-15H,7-9,11-13H2,(H,28,29)(H,24,25,26)
InChI key:InChIKey=LJIFOCRGDDQFJF-UHFFFAOYSA-N
SMILES:O=C(O)CCNC=1N=C(N=C(C1)N2CCC=3C=CC=CC3CC2)C4=CN=CC=C4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK-J2 REF: TM-T11476CAS: 1394854-52-4 | - - - | 50.00 €~503.00 € | Tue 10 Dec 24 |
 | GSK J2 REF: 3D-UFC85452CAS: 1394854-52-4 | Min. 95% | To inquire | Tue 14 Jan 25 |
 | GSK J2 REF: IN-DA009CC6CAS: 1394854-52-4 | 98% | - - - | Discontinued product |
GSK-J2
CAS:1394854-52-4
GSK-J2 is an inactive enantiomer of GSK-J1 that is lipophilic and serves as an inactive …
Formula:
C22H23N5O2
Color and Shape:
Solid
Molecular weight:
389.45
Ref: TM-T11476
| 2mg | 50.00 € | ||
| 5mg | 77.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 162.00 € | ||
| 50mg | 229.00 € | ||
| 100mg | 339.00 € | ||
| 200mg | 503.00 € | ||
| 1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
GSK J2
CAS:1394854-52-4
GSK J2 is a substance that inhibits the activity of histone methyltransferase enzymes. This drug …
Formula:
C22H23N5O2
Purity:
Min. 95%
Molecular weight:
389.45 g/mol
Ref: 3D-UFC85452
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: IN-DA009CC6
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
